Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valganciclovir for the Prevention of Late CMV Infection After Stem Cell Transplant
NCT00275665Phase 3Completed
- Sponsor
- Mayo Clinic
- Start
- Nov 2001
- Primary completion
- Jul 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of valganciclovir in cytomegalovirus infection (CMV), sponsored by Mayo Clinic. Started Nov 2001; status: completed.
02
Drugs
valganciclovir
03
Conditions
cytomegalovirus infection (CMV)
Beyond the preview
Go deeper on NCT00275665.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00275665.